Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
11/2008
11/05/2008EP1309544B1 Compounds acting as melanocortin receptor ligands
11/05/2008EP1303278B1 Combination of a transdermal therapeutic system and an oral and/or parenteral preparation containing dopamine agonists for the treatment of dopaminergic disease states
11/05/2008EP0927196B1 Polymers containing polysaccharides such as alginates or modified alginates
11/05/2008EP0912601B2 Suppression of immune response via inhibition of cathepsin s
11/05/2008CN101300346A Novel biological substance nesfatin and its related substances and uses thereof
11/05/2008CN101300030A Combination of an angiotensin II receptor blocker, a calcium channel blocker and another active agent
11/05/2008CN101298481A Inhibitors of complement activation
11/05/2008CN101297970A Antimetabolites and potentiating agent thereof carried by anticancer sustained-release injection
11/05/2008CN101297969A Combinations of the peroxisome proliferator-activated receptor (PPAR) activator fenofibrate with sterol absorption inhibitor ezetimibe for vascular indications
11/05/2008CN100430478C CASB618 polynucleotides and polypeptides and their use
11/05/2008CN100430414C Tripeptides having a hydroxyproline ether of a substituted quinoline for the inhibition of NS3 (hepatitis C)
11/05/2008CN100430399C Methods and compositions comprising nitric oxide donors and opioid analgesics
11/05/2008CN100430383C Benzimidazoles that are useful in treating sexual dysfunction
11/05/2008CN100430091C Cholerythrin standard liquid, its preparation and preservation method
11/05/2008CN100430067C Carboxylate-gated-nitroxide (CGN) compounds and compositions and methods of use thereof
11/05/2008CN100430063C Combination therapy wherein a serotonin reuptake inhibitor is used
11/05/2008CN100430061C The use of endoperoxides for the treatment of infections caused by flaviviridae, including hepatitis c, bovine viral diarrhea and classical swine fever virus
11/05/2008CN100430060C Combination administration of an indolinone with a chemotherapeutic agent for cell proliferation disorders
11/05/2008CN100430056C Use of MGLUR5 antagonists for the treatment of GERD
11/05/2008CN100430052C Cathepsin cysteine protease inhibitors
11/05/2008CN100430048C Alpha-2-delta ligand to treat lower urinary tract symptoms
11/05/2008CN100430046C Composition and method for treating age-related disorders
11/04/2008US7446168 Endocrine gland-derived vascular endothelial growth factor (EG-VEGF) for use as a tool in treatment and prevention of urogenital and cell proliferative disorders; fertility aide
11/04/2008US7446091 Methods and preparations for curing clinically ill patients
11/04/2008US7445801 Stable bicarbonate-based solution in a single container
11/04/2008US7445779 Methods of modulating IFNy production
11/04/2008US7445768 Delivery of sedative-hypnotics through an inhalation route
11/04/2008CA2457361C Opioid agonist formulations with releasable and sequestered antagonist
11/04/2008CA2332814C Combination therapy for treatment of refractory depression
11/04/2008CA2261805C Promotion of wound healing by chemically-modified tetracyclines
10/2008
10/30/2008WO2008129874A1 Method of targeting tumor cell and use of the same
10/30/2008WO2008129851A1 Nitric oxide synthase activator
10/30/2008WO2008129270A2 Compositions comprising anti-inflammatory compounds
10/30/2008WO2008128792A1 Combination of progesterone-receptor antagonist together with none-steroidal antiestrogen for use in brca mediated diseases
10/30/2008WO2008128791A2 Progesterone-receptor antagonist for use in brca-mediated cancer alone or as combination with antiestrogen
10/30/2008WO2008128784A1 Combination of progesterone-receptor antagonist together with an aromatase inhibitor for prophylaxis or treatment of brca mediated diseases
10/30/2008WO2008128366A1 Active ingredient combination for the prophylaxis of occlusive vascular diseases and cancer
10/30/2008WO2008067045A3 Crystals and structures of ron kinase
10/30/2008WO2008046860A3 Bioavailable combinations for hcv treatment
10/30/2008WO2008036678A3 Combination comprising a peroxisome proliferator activated receptor agent and a second neurogenic agent for treating a nervous system disorder, increasing neurodifferentiation and increasing neurogenesis
10/30/2008WO2008008356A3 Fret-based apoptosis detector
10/30/2008WO2007017768A3 Novel uses for drugs targeting glutamine synthetase
10/30/2008US20080269344 respiratory diseases such as asthma, chronic obstructive pulmonary disease, bronchitis; useful in the treatment of nervous system injury and premature labor; 1-{2-[N-2-(4-hydroxy-3-formylaminophenyl)-2-(RS) hydroxyethyl]aminoethyl}-4-[N-(2-phenyl-2-(RS)-hydroxyethyl)amino]phenyl; milveterol
10/30/2008US20080269304 Parakeratosis inhibitor, pore-shrinking agent and skin preparation for external use
10/30/2008US20080269184 Niosome Having Metal Porphyrin Complex Embedded Therein, Process For Producing The Same And Drug With The Use Thereof
10/30/2008US20080269147 Used in targeting specific mRNAs for degradation in mammalian cells where use of long dsRNAs to elicit RNAi is usually not practical, presumably because of the deleterious effects of the interferon response; autoimmune disease; tumor-associated gene
10/30/2008US20080268066 Synergistic Formulation for Preventing and/or Treating Diabetes
10/30/2008US20080268027 Oral administering a drug; drying self-supporting polymer film and drug dosage
10/30/2008US20080268024 Compositions for Oral and/or Topical Administration
10/30/2008US20080268004 Stable Water-In-Oil-In-Water Multiple Emulsion System Produced By Hydrodynamic Dual Stabilization And A Method For Preparation Thereof
10/30/2008US20080267968 Using cocktail comprising endothelial growth factor specific immunoglobulin and chemotherapeutic agent to treat and/or prevent cervical cancer
10/30/2008US20080267958 Lymphatic endothelial glycoprotein for use as tool in identifying modulators for prevention and treatment of inflammation and cell proliferative disorders
10/30/2008US20080267932 Lactobacillus Rhamnosus with Body-Fat Reducing Activity and the Foods Containing Them
10/30/2008US20080267921 Cardiac Stem Cells
10/30/2008US20080267905 Antiinflammatory; angiogenesis inhibitors; synergistic; kits
10/30/2008US20080267863 Method of Diagnosing, Monitoring, Staging, Imaging and Treating Colon Cancer
10/30/2008DE102007020152A1 Mittel zur antiinfektiven Behandlung eines Patienten Anti-infective agent for treatment of a patient
10/30/2008CA2684806A1 Combination of progesterone-receptor antagonist together with an aromatase inhibitor for prophylaxis or treatment of brca mediated diseases
10/30/2008CA2684084A1 Combination of progesterone-receptor antagonist together with none-steroidal antiestrogen for use in brca mediated diseases
10/30/2008CA2683809A1 Progesterone-receptor antagonist for use in brca alone or as combination with antiestrogen
10/29/2008EP1985703A2 Peripheral nervous system specific sodium channels, DNA encoding therefor, crystallization, X-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof
10/29/2008EP1985634A1 Modulators of p-selectin glycoprotein ligand 1
10/29/2008EP1985632A2 Use of VEGF2 antibodies for inhibiting photoreceptor cell proliferation
10/29/2008EP1985309A1 Nanoparticle containing water-soluble non-peptidic low molecular weight substance
10/29/2008EP1985307A2 Method and preparation for preventing and/or treating depression
10/29/2008EP1985306A2 TRX1 antibody and uses therefor
10/29/2008EP1985283A1 Gel-forming composition for medical use, devices for the application of the composition, and drug release controlling carrier
10/29/2008EP1984026A2 Compositions and methods for treating cardiovascular, cerebrovascular and other vascular disease patients
10/29/2008EP1984010A2 Methods using hydralazine compounds and isosorbide dinitrate or isosorbide mononitrate
10/29/2008EP1983975A2 Method of treatment for muscular dystrophy
10/29/2008EP1539242A4 A composition and method to augment and sustain neurotransmitter production
10/29/2008EP1505959B1 Use of edg receptor binding agents in cancer
10/29/2008EP1425264B1 C2-disubstituted indane-1-ol systems and their use as medicaments
10/29/2008EP1317256B1 Pharmaceutical composition having modified carrier
10/29/2008EP1278574B1 Topical composition for the treatment of psoriasis and related skin disorders
10/29/2008EP1156823B1 Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies
10/29/2008EP1071460B1 INTERNALIZING ErbB2 ANTIBODIES
10/29/2008EP1054693B1 Inhibitors of complement activation
10/29/2008EP0898580B3 Methods and means for inhibition of cdk4 activity
10/29/2008EP0752872B1 Nadh oxidase as a target in diagnosis and therapy
10/29/2008CN101297038A Method for prediction of effectiveness of RAR-alpha agonist
10/29/2008CN101296707A Method for prevention and/or treatment of rheumatoid arthritis
10/29/2008CN101293073A Chinese medicinal composition for treating systematic lupus erythematosus
10/29/2008CN101292956A Sustained-release injection containing methotrexate and its synergistic agent
10/29/2008CN101292955A Sustained-release injection containing fluorouracil synergistic agent and preparation method thereof
10/29/2008CN101292954A Anti-cancer medicament sustained-release injection
10/29/2008CN100428958C Implant agent for treating ophthalmopathy
10/29/2008CN100428957C A fibroid magnetic medicament and preparation method thereof
10/29/2008CN100428956C Use of aza decyl meta pentalkenylone compounds
10/29/2008CN100428936C 抗病毒化合物 Antiviral compounds
10/28/2008US7442837 Phenethanolamine derivatives for treatment of respiratory diseases
10/28/2008US7442836 Phenethanolamine derivatives for treatment of respiratory diseases
10/28/2008US7442720 concurrent administration of cysteamine hydrochloride with metformin
10/28/2008US7442719 Methods using phenethanolamine derivatives for treatment of respiratory diseases
10/28/2008US7442703 Piperidine derivatives useful as CCR5 antagonists
10/28/2008US7442699 For treatment of rheumatoid arthritis, inflammatory or autoimmune condition, viral infection, cancer; 4-{[4-(4-chlorophenyl)pyrimidin-2-yl]amino}benzamide
10/28/2008US7442550 Detection is established by the fusogenic power of the polypeptide, which is demonstrated by syncytia formation; use in drug testing or drug screening; HERV-W envelope glycoprotein; cancer gene therapy
10/28/2008US7442513 Method of screening for agents that modulate a homer signaling pathway
10/28/2008US7442368 Rapidly producing peak plasma concentration; condensation aerosol containing ephedrine and/or fenfluramine; vaporization without degradation
10/28/2008CA2373868C Compositions comprising organosiloxane resins for delivering oral care substances
1 ... 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 ... 1151